SUSQUEHANNA INTERNATIONAL GROUP, LLP
Position in BLLN — BillionToOne, Inc.
CIK 1446194
BALA CYNWYD, PA
Position in BLLN
as of Mar 31, 2026
· filed May 15, 2026
Position Value
$985,644
New position
Shares Held
12,486
first reported quarter
Ownership
0.027%
of shares outstanding
% of Portfolio
0.00%
of 13F equity value
Holder Rank
—
not a current holder
Holding Since
Mar 2026
1 quarter on record
Voting authority
Sole 100%
Shared 0%
None 0%
Derivatives in BLLN
reported options exposure · as of Mar 31, 2026CallValue
$1,097,266
CallShares
13,900
PutValue
$1,957,712
PutShares
24,800
Notional value of option positions as reported on Form 13F. Calls and puts are disclosed separately and do not net against the common-share stake above.
Position in Diagnostics & Research
Healthcare · as of Mar 31, 2026SUSQUEHANNA INTERNATIONAL GROUP, LLP holds $220,999,669 across 38 Diagnostics & Research names. BLLN ranks #22 (0.4% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | DHR |
Danaher Corp /De/
|
240,547 | $45,607,710 | |
| 2 | NTRA |
Natera, Inc.
|
199,638 | $39,925,603 | |
| 3 | TMO |
Thermo Fisher Scientific Inc.
|
64,399 | $31,654,039 | |
| 4 | GRAL |
GRAIL, Inc.
|
304,808 | $15,752,477 | |
| 5 | IDXX |
Idexx Laboratories Inc /De
|
14,061 | $7,900,735 | |
| 6 | QGEN |
Qiagen N.V.
|
185,900 | $7,443,436 | |
| 7 | IQV |
Iqvia Holdings Inc.
|
42,781 | $7,295,871 | |
| 8 | GH |
Guardant Health, Inc.
|
75,989 | $7,019,103 |
All Filings in BLLN
Export CSV
3 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-03-31 | $1,957,712 | 24,800 | Put | Other | 2026-05-15 | |
| 2026-03-31 | $1,097,266 | 13,900 | Call | Other | 2026-05-15 | |
| 2026-03-31 | $985,644 | 12,486 | Shares | Other | 2026-05-15 | |
| No filing history on record for this holder in this stock. | ||||||